Showing results (281-290 of 377) with videos related to
Sort By:
Pageof 38
Research Square|February 23, 2026
Identification of Early Symptoms Associated with Subsequent Immune-related Adverse Events in the I-SPY clinical trialAmrita Basu, Saumya Umashankar, Michelle Melisko, et al.JNCI Cancer Spectrum|May 25, 2026
Outcomes and treatment patterns in germline BRCA1/2 carriers from two matched cohortStefania Morganti, Se E Kim, Qingchun Jin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2026
The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual DiseaseNatasha B Hunter, Heather A Parsons, Leslie Cope, et al.The New England Journal of Medicine|January 28, 2026
Palbociclib for Hormone-Receptor-Positive, HER2-Positive Advanced Breast CancerOtto Metzger, Sumithra Mandrekar, Shom Goel, et al.Annals of Internal Medicine|October 3, 2007
Validity of models for predicting BRCA1 and BRCA2 mutationsGiovanni Parmigiani, Sining Chen, Edwin S Iversen, et al.JAMA|October 28, 2011
Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trialMartin M Oken, Willam G Hocking, Paul A Kvale, et al.Cell Reports. Medicine|December 12, 2023
Protein signaling and drug target activation signatures to guide therapy prioritization: Therapeutic resistance and sensitivity in the I-SPY 2 TrialRosa I Gallagher, Julia Wulfkuhle, Denise M Wolf, et al.JCO Precision Oncology|June 17, 2025
Immune Subtyping Identifies Patients With Hormone Receptor-Positive Early-Stage Breast Cancer Who Respond to Neoadjuvant Immunotherapy (IO): Results From Five IO Arms of the I-SPY2 TrialDenise M Wolf, Christina Yau, Michael Campbell, et al.Cancer Prevention Research (Philadelphia, Pa.)|September 7, 2011
Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal statusSteven J Skates, Phuong Mai, Nora K Horick, et al.Annals of Surgical Oncology|August 23, 2025
Impact of Time to Surgery Post Neoadjuvant Chemotherapy on Breast Cancer Outcomes: A Retrospective Study of Patients Enrolled in the I-SPY 2 Clinical TrialJulie Van Hassel, Katrina Dimitroff, Christina Yau, et al.Pageof 38